naratriptan and Pregnancy studies

naratriptan and Pregnancy

naratriptan has been researched along with Pregnancy in 3 studies

naratriptan: structure given in first source

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research Excerpts

Excerpt	Relevance	Reference
"Using the Marketscan database, the risk of major birth defects was ascertained in live-born infants whose birth mothers were exposed to sumatriptan, naratriptan, or sumatriptan/naproxen during pregnancy."	3.88	Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study. ( Bollinger, L; Cangialose, C; Chia, V; Mikol, DD; Xue, F; Yusuf, A, 2018)
"Accumulated data suggest that exposure to sumatriptan during pregnancy does not increase the risk of birth defects above the baseline rate."	3.76	Safety of triptans for migraine headaches during pregnancy and breastfeeding. ( Bozzo, P; Duong, S; Einarson, A; Nordeng, H, 2010)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

3 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Yusuf, A	1
Chia, V	1
Xue, F	1
Mikol, DD	1
Bollinger, L	1
Cangialose, C	1
Diener, HC	1
Duong, S	1
Bozzo, P	1
Nordeng, H	1
Einarson, A	1

Studies

Yusuf, A

Chia, V

Xue, F

Mikol, DD

Bollinger, L

Cangialose, C

Diener, HC

Duong, S

Bozzo, P

Nordeng, H

Einarson, A

Other Studies

3 other studies available for naratriptan and Pregnancy

Article	Year
Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:12 Topics: Abnormalities, Drug-Induced; Administrative Claims, Healthcare; Adolescent; Adult; Databases, Factua	2018
[Pregnant women can take triptans]. MMW Fortschritte der Medizin, 2014, Oct-23, Volume: 156, Issue:18 Topics: Congenital Abnormalities; Female; Humans; Naproxen; Piperidines; Pregnancy; Sumatriptan; Tryptamines	2014
Safety of triptans for migraine headaches during pregnancy and breastfeeding. Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:6 Topics: Breast Feeding; Female; Humans; Migraine Disorders; Piperidines; Pregnancy; Pregnancy Complications;	2010

Article

Year

Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.

Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:12

Topics: Abnormalities, Drug-Induced; Administrative Claims, Healthcare; Adolescent; Adult; Databases, Factua

2018

[Pregnant women can take triptans].

MMW Fortschritte der Medizin, 2014, Oct-23, Volume: 156, Issue:18

Topics: Congenital Abnormalities; Female; Humans; Naproxen; Piperidines; Pregnancy; Sumatriptan; Tryptamines

2014

Safety of triptans for migraine headaches during pregnancy and breastfeeding.

Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:6

Topics: Breast Feeding; Female; Humans; Migraine Disorders; Piperidines; Pregnancy; Pregnancy Complications;

2010